Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…prove patient survival rates. However, commonly used drugs like tacrolimus (TAC) and mycophenolate mofetil (MMF) have a narrow therapeutic…
…onthly CYC pulses (750 mg/m 2) followed by at least one year of mycophenolate mofetil. Criteria for rescue HSCT or DMARD use post-HSCT were predefine…
… mean disease duration was 7.2±6.2 years. All patients received prednisolone at mean dose of 10.6±4.3 mg/day. 9% of patients received cyclop…
…nts recieved corticosteroids, and 48.7% recieved antimalarials. Mycophenolate mofetil, rituximab and cyclophosphamide were the most commonly used imm…
… profibrotic or proinflammatory cytokines and then treated with nerandomilast. Investigations included cell proliferation, fibrosis-associate…
… of 22.2 months (95% CI 18.1-26.2), 51% of patients interrupted nintedanib due to diarrhoea (33%), nausea/vomiting (21%), reflux (2%), wei…
… (SSc) patients. The recent ERS/EULAR guidelines recommend both mycophenolate mofetil (MMF) and rituximab (RTX) for SSc-ILD and suggest to use a comb…
…analyze long term outcome of patients with SSc-ILD treated with tocilizumab (TCZ), rituximab (RTX), and abatacept (ABA) which became availa…
…through CMR. Based on recent evidence, combination therapy with rituximab (RTX, 2 x 1000 mg with a two-week gap and a repeat dose after s…
…SP was 21mmHg. HRCT Scan confirmed mild ILD.He was commenced on mycophenolate mofetil, amlodipine and omeprazole. Mid-2023 he presented with shortnes…
… fibrin, but no active infection or granuloma.Results Following Rituximab and subsequent initiation of mycophenolate mofetil (MMF), there…
…with intravenous cyclophosphamide (cumulative 6 g), followed by mycophenolate mofetil (2 g/day), leading to initial clinical and laboratory improveme…